Cyclandelate

Chemical compound
  • C04AX01 (WHO)
Identifiers
  • 3,3,5-trimethylcyclohexyl hydroxy(phenyl)acetate
CAS Number
  • 456-59-7
PubChem CID
  • 2893
DrugBank
  • DB04838 checkY
ChemSpider
  • 2790 checkY
UNII
  • 4139O1OAY2
KEGG
  • D00286 checkY
ChEBI
  • CHEBI:3988 checkY
ChEMBL
  • ChEMBL1480987
CompTox Dashboard (EPA)
  • DTXSID4022862 Edit this at Wikidata
ECHA InfoCard100.006.611 Edit this at WikidataChemical and physical dataFormulaC17H24O3Molar mass276.376 g·mol−13D model (JSmol)
  • Interactive image
Melting point55 to 56.5 °C (131.0 to 133.7 °F)Boiling point192 to 194 °C (378 to 381 °F) (14 mmHg)
  • O=C(OC1CC(CC(C1)(C)C)C)C(O)c2ccccc2
InChI
  • InChI=1S/C17H24O3/c1-12-9-14(11-17(2,3)10-12)20-16(19)15(18)13-7-5-4-6-8-13/h4-8,12,14-15,18H,9-11H2,1-3H3 checkY
  • Key:WZHCOOQXZCIUNC-UHFFFAOYSA-N checkY
  (verify)

Cyclandelate is a vasodilator used in the treatment of claudication, arteriosclerosis and Raynaud's disease.[1] It is also used to treat nighttime leg cramps, and has been investigated for its effect against migraine. It is orally administered.

References

  1. ^ Smith AL (January 1965). "Cyclandelate (Cyclospasmol) in the Treatment of Peripheral Circulatory Diseases". Angiology. 16: 1–7. doi:10.1177/000331976501600101. PMID 14258038.


Stub icon

This drug article relating to the cardiovascular system is a stub. You can help Wikipedia by expanding it.

  • v
  • t
  • e